KKR & Co. Inc. reports developments across its global investment business, including alternative asset management, capital markets activity and insurance solutions. Company news commonly covers operating results, fund and strategy activity, portfolio investments, co-investment vehicles, debt financing, and capital-structure updates.
KKR sponsors investment funds in private equity, credit and real assets, works with strategic partners that manage hedge fund platforms, and operates insurance subsidiaries that offer retirement, life and reinsurance products through Global Atlantic Financial Group. Recent company updates also reflect activity in technology growth, sports, sustainable infrastructure and insurance-related platforms.
Darwinbox, a global HR technology platform, has secured a $140 million investment co-led by Partners Group and KKR, with participation from Gravity Holdings. Founded in 2015, Darwinbox serves over 1,000 enterprises worldwide with its mobile-first and AI-enabled human capital management platform.
The company has achieved significant international expansion, with a fivefold growth in revenue in international markets over the last two years, with over 60% of new revenue coming from these markets. Darwinbox operates across Asia Pacific, the Middle East, the UK, and the US, serving over 3 million employees from brands including Starbucks, Nivea, AXA, and Cigna.
In 2024, Darwinbox was recognized as a Challenger in the Gartner Magic Quadrant for Cloud HCM Suites, becoming the youngest and only Asian company to receive this recognition. The investment will support Darwinbox's technology leadership and accelerate its international expansion plans.
KKR has announced the sale of Seiyu, a major Japanese supermarket chain, to Trial Holdings. KKR, which currently holds an 85% stake (65% acquired from Walmart in 2021 and 20% from Rakuten in 2023), will exit alongside Walmart, which will sell its remaining 15% stake.
Under KKR's ownership, Seiyu underwent significant transformations including:
- Enhanced product quality and selection, particularly in fresh produce and in-house brands
- Implementation of technological solutions like self-checkout and automatic restocking systems
- Transformation from a General Merchandise Store to a supermarket format
- Digital infrastructure modernization
The transaction, made from KKR's Asian Fund IV, is expected to close in Q2 2025, subject to regulatory approvals.
KKR (NYSE: KKR) has successfully priced its upsized offering of 6.25% Series D Mandatory Convertible Preferred Stock at $2.25 billion, representing 45 million shares at $50.00 per share. This marks a significant increase from the initially announced $1.50 billion offering.
The offering, expected to close on March 7, 2025, will generate net proceeds of approximately $2.20 billion, potentially reaching $2.53 billion if underwriters exercise their over-allotment option. The funds will be used for acquiring additional equity interests in core private equity portfolio companies within KKR's Strategic Holdings segment.
Each preferred stock share will automatically convert to common stock on March 1, 2028, with a conversion rate between 0.3312 and 0.4140 shares. Dividends will be paid quarterly at a 6.25% annual rate, starting June 1, 2025. The preferred stock will be listed on NYSE under the symbol 'KKR PR D'.
KKR (NYSE: KKR) has announced a $1.5 billion offering of Series D Mandatory Convertible Preferred Stock, consisting of 30 million shares at $50.00 per share liquidation preference. The company is also granting underwriters a 30-day option for an additional $225 million (4.5 million shares) to cover potential over-allotments.
The proceeds will be used to acquire additional equity interests in core private equity portfolio companies within KKR's Strategic Holdings segment and for general corporate purposes. The preferred stock will automatically convert into a variable number of common stock shares around March 1, 2028, unless converted earlier by holders.
Morgan Stanley & Co. and KKR Capital Markets are serving as joint book-running managers for the offering, which is being conducted through an effective shelf registration statement filed with the SEC.
Ajax Health, backed by KKR, has announced the formation of FlowMod, a new collaboration with Boston Scientific to develop a heart failure treatment system. The initiative aims to accelerate development, clinical validation, and regulatory approval for treating a condition affecting 64 million people worldwide.
FlowMod will be led by CEO Dr. Philippe Marco, former President and COO of Epix Therapeutics and CV Ingenuity. The venture is supported by KKR's Health Care Strategic Growth Fund II, a $4.0 billion fund focused on high-growth healthcare companies. The platform will utilize intellectual property developed by Boston Scientific to create a differentiated solution for physicians and patients in heart failure treatment.
KKR, a global investment firm, has announced a bespoke financing solution for Family Doctor, one of Australia's leading GP clinic networks. The financing will enable Family Doctor to accelerate its growth and expansion plans while maintaining its 100% doctor-owned status.
Founded in 2008, Family Doctor operates more than 110 GP-run clinics across key metropolitan and regional areas in Australia, including Victoria, Queensland, Western Australia, New South Wales, the Australian Capital Territory, and South Australia.
The investment comes from KKR's Asia Pacific Credit strategy, which has completed over 50 credit investments in Asia Pacific since 2019, with total transaction value approaching US$21 billion. This partnership will allow Family Doctor to leverage KKR's global network and expertise while pursuing its mission of providing quality healthcare services.
FS KKR Capital Corp. (FSK) has announced its Q4 and full-year 2024 results, along with declaring a Q1 2025 distribution of $0.70 per share. The Q4 results show net investment income of $0.61 per share, down from $0.77 in Q3 2024. The company's net asset value decreased to $23.64 per share from $23.82 in Q3 2024.
For the full year 2024, FSK reported net investment income of $2.90 per share compared to $3.18 in 2023. The investment portfolio totaled $13.5 billion, with 63.8% invested in senior secured securities. The weighted average annual yield on accruing debt investments was 11.3%, down from 11.9% in Q3 2024.
The company maintains a strong liquidity position with $4.8 billion available and a net debt to equity ratio of 104%. Non-accrual investments represented 2.2% of the portfolio at fair value, up from 1.7% in Q3 2024.
KKR has announced the acquisition of a controlling stake in Healthcare Global Enterprises (HCG), India's leading oncology hospital chain. KKR will acquire up to 54% equity from CVC Asia V at INR 445 per share, with potential ownership between 54-77% following an open offer to public shareholders. The deal values at approximately $400 million.
Founded in 1989, HCG operates 25 medical centers across 19 Indian cities, featuring 2,500 beds, nearly 100 operating theaters, and 40 linear accelerator machines. Dr. BS Ajaikumar, HCG's founder, will transition to Non-Executive Chairman, focusing on clinical excellence and R&D.
The transaction, funded through KKR's Asia Fund IV, is expected to close by Q3 2025, subject to regulatory approvals. This marks KKR's latest investment in India's healthcare sector, following investments in Baby Memorial Hospital, Healthium, Infinx, Max Healthcare, JB, and Gland Pharma.
KKR has announced its first residential investment in Stockholm through a forward-purchase agreement with Swedish developers Reliwe and The Derome Group for three multifamily properties in Haninge. The development comprises 382 residential units, expected for completion between late 2026 and early 2027.
The project includes two timber construction properties built by Derome and one traditional concrete construction asset. Located near a bus terminal and railway station, the development aims to deliver affordable modern urban living with premium amenities while meeting high environmental standards.
Over the past two years, KKR has committed approximately $550 million (SEK 6 billion) to Nordic real estate investments. The company will work with local operating partner Cavendo to manage and grow the Stockholm residential platform.
KKR has successfully completed its tender offer for FUJI SOFT, becoming the largest shareholder with a 57.92% ownership stake. The second stage of the tender offer concluded on February 19, 2025, with settlement scheduled for February 27, 2025. KKR plans to acquire the remaining shares through a squeeze-out process, aiming for 100% ownership, with an Extraordinary General Meeting planned for late April 2025.
FUJI SOFT, a leading Japanese system integration company with over 10,000 system engineers, achieved record-high performance in FY2024 with revenue of 317.5 billion yen and operating income of 22 billion yen (6.5% margin). The tender offer process was extended by four months due to a competing proposal from Bain Capital. The acquisition will be primarily financed through KKR Asian Fund IV.